IL-23A和IL-17A在CIN及子宫颈癌中的表达及意义被引量：10

Expressions of IL-23A and IL-17A in CIN and SCC and their clinical significance

导出

摘要目的探讨白细胞介素23A（interleukin-23A,IL-23A）和IL-17A在不同等级子宫颈上皮内瘤变（cervical intraepithelial neoplasia,CIN）及子宫颈鳞状细胞癌中的表达水平及相关性。方法收集临床标本89例,其中20例健康对照（无感染或病变）,11例低级别CIN,36例高级别CIN（CINⅡ-Ⅲ）;22例子宫颈鳞状细胞癌。ELISA检测血清及子宫颈分泌物中IL-23A和IL-17A的表达及其相关性。第二代杂交捕获试验检测子宫颈分泌物中人乳头状瘤病毒（human papillomavirus,HPV）DNA的表达情况,分析IL-23A和IL-17A的表达与临床预后及HPV感染的关系。结果与对照组比较,IL-23A和IL-17A在CIN和子宫颈癌分泌物及血清中呈高表达,差异有统计学意义（均P〈0.05）。子宫颈癌患者血清IL-23A与IL-17A的表达呈正相关（r=0.865,P〈0.01）,子宫颈癌患者血清IL-23A、IL-17A高表达患者的生存时间明显缩短（均P〈0.01）。IL-23A和IL-17A的表达与HPV的感染有关（P〈0.01）。结论 IL-23A和IL-17A在子宫颈上皮内瘤变和子宫颈癌中高表达,有望作为早期预测子宫颈病变的生物标志物。 Objective To investigate the expressions of IL-23 A and IL-17 A in cervical intraepithelial neoplasia（CIN） and squamous cervical carcinoma（SCC） and their clinical significance. Methods Twenty-two patients with squamous cervical carcinoma（ SCC）,47 patients with cervical intraepithelial neoplasia（ including 11 with CIN I and 36 with CIN Ⅱ-Ⅲ） and 20 healthy women（ control group） were enrolled in this study. The IL-23 A and IL-17 A levels in the cervical secretions and serum were examined by enzyme-linked immunosorbent assay（ ELISA）. Human papillomavirus（ HPV）DNA in cervical smears was detected by PCR screening kits. The correlations of IL-23 A and IL-17 A levels with cervical disorders and with HPV infection were analyzed. Results Compared with the control group,IL-23 A and IL-17 A levels were both increased in cervical secretions and in serum of patients with CIN and SCC（ P〈0. 05）. The levels of IL-23 A and IL-17 A in the serum of SCC patients were positively correlated（ r = 0. 865,P〈0. 01）. The IL-23 A and IL-17 A levels were negatively associated with the survival of SCC patients（ P〈0. 01）. IL-23 A and IL-17 A levels were associated with HPV infections（ P〈0. 01）. Conclusion Elevated levels of IL-23 A and IL-17 A in cervical secretion and serum are observed in CIN and SCC patients,which may serve as additional biomarkers for diagnosis and prognosis of cervical disorders.

作者高俊李艳琴刘兮陈燕高鑫

机构地区成都双流县妇幼保健院妇产科

出处《实用肿瘤杂志》 CAS 2016年第2期157-162,共6页 Journal of Practical Oncology

关键词宫颈肿瘤/病理学宫颈上皮内瘤样病变/病理学肿瘤鳞状细胞白细胞介素17 白细胞介素23 基因表达酶联免疫吸附测定预后 uterine cervical neoplasms/pathology cervical intraepithelial neoplasia/pathology neoplasms squamous cell interleukin-17 interleukin-23 gene expression enzyme-linked immunosorbent assay prognosis

分类号 R737.33 [医药卫生—肿瘤] R730.23 [医药卫生—肿瘤]

引文网络
相关文献

参考文献20

1Izadi-Mood N, Sarmadi S, Eftekhar Z,et al. Immunohisto-chemical expression of pi 6 and HPV LI capsid proteinsas predictive markers in cervical lesions [ J ]. Arch Gyne-col Obstet,2014,289(6) :1287 - 1292.
2Stanley M. Pathology and epidemiology of HPV infectionin females[ J]. Gynecol Oncol,2010,117(2 Suppl) :S5 -10.
3Baird AM,Leonard J,Naicker KM,et al. IL-23 is pro-pro-liferative, epigenetically regulated and modulated bychemotherapy in non-small cell lung cancer [ J ]. LungCancer,2013,79(l) :83 -90.
4Lan F,Zhang L,Wu J,et al. IL-23/IL-23R:potential me-diator of intestinal tumor progression from adenomatouspolyps to colorectal carcinoma [ J ]. Int J Colorectal Dis,2011,26(12) :1511 -1518.
5Ates I, Ozkayar N,Akyel F, et al. The relationship be-tween asymptomatic organ damage, and serum solubletumor necrosis factor-like weak inducer of apoptosis(sTWEAK ) and Interleukin-17A ( IL-17A ) levels innon-diabetic hypertensive patients [ J ]. BMC Nephrol,2014,15(1) :159 -168.
6Gursoy UK, Yildiz Ciftlikli S, Kononen E, et al. Salivary11-17 and Tnf-A in relation to periodontitis and glycemicstatus in type 2 diabetes mellitus[ J]. J Diabetes,2014,21(4):19 -26.
7Karbach S, Croxford AL,Oelze M, et al. Interleukin 17drives vascular inflammation,endothelial dysfunction,andarterial hypertension in psoriasis-like skin disease [ J ]. Ar-terioscler Thromb Vase Biol,2014,12(6) :59 -66.
8Chen Z,Ding J,Pang N,et al. The Thl7/Treg balance andthe expression of related cytokines in Uygur cervical canc-er patients[ J]. Diagn Pathol,2013 ,8(3) :61 - 68.
9Jakubowicz J, Blecharz P, Skotnicki P, et al. Toxicity ofconcurrent chemoradiotherapy for locally advanced cervi-cal cancer[ J]. Eur J Gynaecol Oncol,2014,35 (4) :393-399.
10Bandera L, La Face B, Antonioli C, et al. Survival andtoxicity of radical radiotherapy ( with or without brachy-therapy) for FIGO stage I and H cervical cancer : amono-institutional analysis [ J ]. Eur J Gynaecol Oncol,2014,35(2) :121 -127.